Topical drug delivery using chitosan nano- and microparticles

Bibliography

• Foldvari M. Biphasic vesicles: a novel topical drug delivery system. J Biomed Nanotechnol 2010;6:543-57
   PubMed Web of Science ®Google Scholar
• Labouta HA, El-Khordagui LK. Polymethacrylate microparticles gel for topical drug delivery. Pharm Res 2010;27:2106-18
   PubMed Web of Science ®Google Scholar
• Ramtoola Z, Lyons P, Keohane K, Investigation of the interaction of biodegradable micro- and nanoparticulate drug delivery systems with platelets. J Pharm Pharmacol 2011;63:26-32
   PubMed Web of Science ®Google Scholar
• Ueno H, Mori T, Fujinaga T. Topical formulations and wound healing applications of chitosan. Adv Drug Deliv Rev 2001;2:105-15
   Web of Science ®Google Scholar
• Peng CC, Yang MH, Chiu WT, Composite nano-titanium oxide-chitosan artificial skin exhibits strong wound-healing effect-an approach with anti-inflammatory and bactericidal kinetics. Macromol Biosci 2008;8:316-27
   PubMed Web of Science ®Google Scholar
• Masotti A, Ortaggi G. Chitosan micro- and nanospheres: fabrication and applications for drug and DNA delivery. Mini Rev Med Chem 2009;4:463-9
   Web of Science ®Google Scholar
• Sezer AD, Hatipoglu F, Cevher E, A new biopolymer fucoidan as a wound dressing for dermal burn healing: preparation and in vitro/in vivo evaluation. AAPS PharmSciTech 2007;8(2):E1-8
   PubMed Web of Science ®Google Scholar
• Ravi Kumar MNV. A review of chitin and chitosan applications. React Funct Polym 2000;46(1):1-27
   Web of Science ®Google Scholar
• Reddy N, Yang Y. Potential of plant proteins for medical applications. Trends Biotechnol 2011;29:490-8
   PubMed Web of Science ®Google Scholar
• Wang JJ, Zeng ZW, Xiao RZ, Recent advances of chitosan nanoparticles as drug carriers. Int J Nanomedicine 2011;6:765-74
   PubMed Web of Science ®Google Scholar
• Duceppe N, Tabrizian M. Advances in using chitosan-based nanoparticles for in vitro and in vivo drug and gene delivery. Expert Opin Drug Deliv 2010;7:1191-207
   PubMed Web of Science ®Google Scholar
• Wadhwa S, Paliwal R, Paliwal SR, Chitosan and its role in ocular therapeutics. Mini Rev Med Chem 2009;14:1639-47
   Web of Science ®Google Scholar
• Janes KA, Calvo P, Alonso MJ. Polysaccharide colloidal particles as delivery systems for macromolecules. Adv Drug Deliv Rev 2001;47:83-97
   PubMed Web of Science ®Google Scholar
• Agnihotri SA, Mallikarjuna NN, Aminabhavi TM. Recent advances on chitosan-based micro- and nanoparticles in drug delivery. J Control Release 2004;100:5-28
   PubMed Web of Science ®Google Scholar
• Paolicelli P, de la Fuente M, Sanchez A, Chitosan nanoparticles for drug delivery to the eye. Expert Opin Drug Deliv 2009;6:239-53
   PubMed Web of Science ®Google Scholar
• Wadhwa S, Paliwal R, Paliwal SR, Vyas SP. Nanocarriers in ocular drug delivery: an update review. Curr Pharm Des 2009;15:2724-50
   PubMed Web of Science ®Google Scholar
• Kaur IP, Smitha R. Penetration enhancers and ocular bioadhesives: two new avenues for ophthalmic drug delivery. Drug Dev Ind Pharm 2002;28:353-69
   PubMed Web of Science ®Google Scholar
• De Campos AM, Diebold Y, Carvalho EL, Chitosan nanoparticles as new ocular drug delivery systems: in vitro stability, in vivo fate, and cellular toxicity. Pharm Res 2004;21:803-10
   PubMed Web of Science ®Google Scholar
• Zambito Y, Zaino C, Di Colo G. Effects of N-trimethylchitosan on transcellular and paracellular transcorneal drug transport. Eur J Pharm Biopharm 2006;64:16-25
   PubMed Web of Science ®Google Scholar
• De La Fuente M, Ravina M, Paolicelli P, Chitosan-based nanostructures: a delivery platform for ocular therapeutics. Adv Drug Deliv Rev 2010;62:100-17
   PubMed Web of Science ®Google Scholar
• Hao J, Li SK, Kao WW, Liu CY. Gene delivery to cornea. Brain Res Bull 2010;81:256-61
   PubMed Web of Science ®Google Scholar
• Berdugo M, Valamanesh F, Andrieu C, Delivery of antisense oligonucleotide to the cornea by iontophoresis. Antisense Nucleic Acid Drug Dev 2003;13:107-14
   PubMedGoogle Scholar
• Mainardes RM, Urban MCC, Cinto PO, Colloidal carriers for ophthalmic drug delivery. Curr Drug Targets 2005;6:363-71
   PubMed Web of Science ®Google Scholar
• Weiner AL, Gilger BC. Advancements in ocular drug delivery. Vet Ophthalmol 2010;13:395-406
   PubMedGoogle Scholar
• Rabinovich-Guilatt L, Couvreur P, Lambert G, Dubernet C. Cationic vectors in ocular drug delivery. J Drug Target 2004;12:623-33
   PubMed Web of Science ®Google Scholar
• Nagarwal RC, Kant S, Singh PN, Polymeric nanoparticulate system: a potential approach for ocular drug delivery. J Control Release 2009;136:2-13
   PubMed Web of Science ®Google Scholar
• De La Fuente M, Seijo B, Alonso MJ. Novel hyaluronic acid-chitosan nanoparticles for ocular gene therapy. Invest Ophthalmol Vis Sci 2008;49:2016-24
   PubMed Web of Science ®Google Scholar
• Williams KA, Coster DJ. Gene therapy for diseases of the cornea – a review. Clin Experiment Ophthalmol 2010;38:93-103
   PubMed Web of Science ®Google Scholar
• Klausner EA, Zhang Z, Chapman RL, Ultrapure chitosan oligomers as carriers for corneal gene transfer. Biomaterials 2010;31:1814-20
   PubMed Web of Science ®Google Scholar
• De Salamanca AE, Diebold Y, Calonge M, Chitosan nanoparticles as a potential drug delivery system for the ocular surface: toxicity, uptake mechanism and in vivo tolerance. Invest Ophthalmol Vis Sci 2006;47:1416-25
   PubMed Web of Science ®Google Scholar
• Prow TW, Bhutto I, Kim SY, Ocular nanoparticle toxicity and transfection of the retina and retinal pigment epithelium. Nanomedicine 2008;4:340-9
   PubMed Web of Science ®Google Scholar
• Motwani SK, Chopra S, Talegaonkar S, Chitosan–sodium alginate nanoparticles as submicroscopic reservoirs for ocular delivery: formulation, optimisation and in vitro characterisation. Eur J Pharm Biopharm 2008;68:513-25
   PubMed Web of Science ®Google Scholar
• Genta I, Conti P, Perugini P, Bioadhesive microspheres for ophthalmic administration of acyclovir. J Pharm Pharmacol 1997;49:737-42
   PubMed Web of Science ®Google Scholar
• De Campos A, Sanchez A, Alonso MJ. Chitosan nanoparticles: a new vehicle for the improvement of the ocular retention of drugs. Application to cyclosporin A. Int J Pharm 2001;224:159-68
   PubMed Web of Science ®Google Scholar
• Rassu G, Gavini E, Jonassen H, New chitosan derivatives for the preparation of rokitamycin loaded microspheres designed for ocular or nasal administration. J Pharm Sci 2009;98:4852-65
   PubMed Web of Science ®Google Scholar
• Yuan XB, Li H, Yuan YB. Preparation of cholesterol-modified chitosan self-aggregated nanoparticles for delivery of drugs to ocular surface. Carbohydr Polym 2006;65:337-45
   Web of Science ®Google Scholar
• Yuan XB, Yuan YB, Jiang W, Preparation of rapamycin-loaded chitosan/PLA nanoparticles for immunosuppression in corneal transplantation. Int J Pharm 2008;349:241-8
   PubMed Web of Science ®Google Scholar
• Kao HJ, Lin HR, Lo YL, Yu SP. Characterization of pilocarpine-loaded chitosan/carbopol nanoparticles. J Pharm Pharmacol 2006;58:179-86
   PubMed Web of Science ®Google Scholar
• Lin HR, Yu SP, Kuo CJ, Pilocarpine-loaded chitosan-PAA nanosuspension for ophthalmic delivery. J Biomater Sci Polymer Ed 2007;18:205-21
   PubMed Web of Science ®Google Scholar
• Lin HR, Yu SP, Lin YJ, Wang TS. High pH tolerance of a chitosan-paa nanosuspension for ophthalmic delivery of pilocarpine. J Biomater Sci Polymer Ed 2010;21:141-57
   PubMed Web of Science ®Google Scholar
• Tian B, Luo Q, Song S, Novel surface-modified nanostructured lipid carriers with partially deacetylated water-soluble chitosan for efficient ocular delivery. J Pharm Sci 2012;101:1040-9
   PubMed Web of Science ®Google Scholar
• Parveen S, Mitra M, Krishnakumar S, Sahoo SK. Enhanced antiproliferative activity of carboplatin-loaded chitosan-alginate nanoparticles in a retinoblastoma cell line. Acta Biomater 2010;6(8):3120-31
   PubMed Web of Science ®Google Scholar
• Abdelbary G. Ocular ciprofloxacin hydrochloride mucoadhesive chitosan-coated liposomes. Pharm Dev Technol 2011;16:44-56
   PubMed Web of Science ®Google Scholar
• Li N, Zhuang CY, Wang M, Low molecular weight chitosan-coated liposomes for ocular drug delivery: in vitro and in vivo studies. Drug Deliv 2012;19:28-35
   PubMed Web of Science ®Google Scholar
• Peptu CA, Buhus G, Popa M, Double cross-linked chitosan—gelatin particulate systems for ophthalmic applications. J Bioact Compat Pol 2010;25:98-116H
   Web of Science ®Google Scholar
• Jain GK, Pathan SA, Akhter S, Microscopic and spectroscopic evaluation of novel PLGA–chitosan nanoplexes as an ocular delivery system. Colloid Surface B Biointerfaces 2011;82:397-403
   PubMed Web of Science ®Google Scholar
• Mahmoud AA, El-Feky GS, Kamel R, Awad GEA. Chitosan/sulfobutylether-beta-cyclodextrin nanoparticles as a potential approach for ocular drug delivery. Int J Pharm 2011;413:229-36H
   PubMed Web of Science ®Google Scholar
• Schroeter A, Engelbrecht T, Neubert RH, Goebel AS. New nanosized technologies for dermal and transdermal drug delivery. A review. J Biomed Nanotechnol 2010;6(5):511-28
   PubMed Web of Science ®Google Scholar
• Basavaraj KH, Johnsy G, Navya MA, Biopolymers as transdermal drug delivery systems in dermatology therapy. Crit Rev Ther Drug Carrier Syst 2010;27(2):155-85
   PubMed Web of Science ®Google Scholar
• Sinico C, Fadda AM. Vesicular carriers for dermal drug delivery. Expert Opin Drug Deliv 2009;6(8):813-25
   PubMed Web of Science ®Google Scholar
• Choksi AN, Poonawalla T, Wilkerson MG. Nanoparticles: a closer look at their dermal effects. J Drugs Dermatol 2010;9(5):475-81
   PubMed Web of Science ®Google Scholar
• Rasool BK, Aziz US, Sarheed O, Rasool AA. Design and evaluation of a bioadhesive film for transdermal delivery of propranolol hydrochloride. Acta Pharm 2011;61(3):271-82
   PubMed Web of Science ®Google Scholar
• Cui Z, Mumper RJ. Chitosan-based nanoparticles for topical genetic immunization. J Control Release 2001;75:409-19
   PubMed Web of Science ®Google Scholar
• Bos JD, Kapsenburg ML. The skin immune system: progress in cutaneous biology. Immunol Today 1993;14:75-8
   PubMedGoogle Scholar
• Lee PW, Peng SF, Su CJ, The use of biodegradable polymeric nanoparticles in combination with a low-pressure gene gun for transdermal DNA delivery. Biomaterials 2008;29(6):742-51
   PubMed Web of Science ®Google Scholar
• Huang HN, Li TL, Chan YL, Transdermal immunization with low-pressure-gene-gun mediated chitosan-based DNA vaccines against Japanese encephalitis virus. Biomaterials 2009;30(30):6017-25
   PubMed Web of Science ®Google Scholar
• Ozbas-Turan S, Akbuga J. Plasmid DNA-loaded chitosan/TPP nanoparticles for topical gene delivery. Drug Deliv 2011;18(3):215-22
   PubMed Web of Science ®Google Scholar
• Ozbas-Turan S, Akbuga J, Sezer AD. Topical application of antisense oligonucleotide-loaded chitosan nanoparticles to rats. Oligonucleotides 2010;20:147-53
   PubMed Web of Science ®Google Scholar
• Bal SM, Ding Z, Kersten GF, Microneedle-based transcutaneous immunisation in mice with N-trimethyl chitosan adjuvanted diphtheria toxoid formulations. Pharm Res 2010;27:1837-47
   PubMed Web of Science ®Google Scholar
• Amidi M, Pellikaan HC, Hirschberg H, Diphtheria toxoid-containing microparticulate powder formulations for pulmonary vaccination: preparation, characterization and evaluation in guinea pigs. Vaccine 2007;25:6818-29
   PubMed Web of Science ®Google Scholar
• Hagenaars N, Mastrobattista E, Verheul RJ, Physicochemical and immunological characterization of N,N,N-trimethyl chitosan-coated whole inactivated influenza virus vaccine for intranasal administration. Pharm Res 2009;26:1353-64
   Web of Science ®Google Scholar
• Bal SM, Slutter B, van Riet E, Efficient induction of immune responses through intradermal vaccination with N-trimethyl chitosan containing antigen formulations. J Control Release 2010;142:374-83
   PubMed Web of Science ®Google Scholar
• Amidi M, Romeijn SG, Verhoef JC, N-trimethyl chitosan (TMC) nanoparticles loaded with influenza subunit antigen for intranasal vaccination: biological properties and immunogenicity in a mouse model. Vaccine 2007;25:144-53
   PubMed Web of Science ®Google Scholar
• Schlosser E, Mueller M, Fischer S, TLR ligands and antigen need to be coencapsulated into the same biodegradable microsphere for the generation of potent cytotoxic T lymphocyte responses. Vaccine 2008;26(13):1626-37
   PubMed Web of Science ®Google Scholar
• Degim Z. Use of microparticulate systems to accelerate skin wound healing. J Drug Target 2008;16:437-48
   PubMed Web of Science ®Google Scholar
• Liu HF, Fan HB, Cui YL, Effects of the controlled-released basic fibroblast growth factor from chitosan-gelatin microspheres on human fibroblasts cultured on a chitosan-gelatin scaffold. Biomacromolecules 2007;8:1446-55
   PubMed Web of Science ®Google Scholar
• Sezer AD, Cevher E, Hatipoglu F, The use of fucosphere in the treatment of dermal burns in rabbits. Eur J Pharm Biopharm 2008;69:189-98
   PubMed Web of Science ®Google Scholar
• Lu SY, Gao WJ, Gu HY. Construction, application and biosafety of silver nanocrystalline chitosan wound dressing. Burns 2008;34:623-8
   PubMed Web of Science ®Google Scholar
• Perugini P, Hassan K, Genta I, Intracellular delivery of liposome-encapsulated prolidase in cultured fibroblasts from prolidase-deficient patients. J Control Release 2005;102:181-90
   PubMed Web of Science ®Google Scholar
• Colonna C, Conti B, Genta I, Alpar O. Non-viral dried powders for respiratory gene delivery prepared by cationic and chitosan loaded liposomes. Int J Pharm 2008;70:58-65
   Google Scholar
• Colonna C, Conti B, Perugini P, Ex vivo evaluation of prolidase loaded chitosan nanoparticles for the enzyme replacement therapy. Eur J Pharm Biopharm 2008;70:58-65
   PubMed Web of Science ®Google Scholar
• Senyigit T, Sonvico F, Barbieri S, Lecithin/chitosan nanoparticles of clobetasol-17-propionate capable of accumulation in pig skin. J Control Release 2010;142:368-73
   PubMed Web of Science ®Google Scholar
• Hasanovic A, Reznicek G, Zehl M, Valenta C. Chitosan-TPP nanoparticles as possible skin drug delivery system for acyclovir with enhanced stability. J Pharm Pharmacol 2009;61:1609-16
   PubMed Web of Science ®Google Scholar
• Tang DW, Yu SH, Ho YC, Heparinized chitosan/poly(gamma-glutamic acid) nanoparticles for multi-functional delivery of fibroblast growth factor and heparin. Biomaterials 2010;31(35):9320-32
   PubMed Web of Science ®Google Scholar
• Hafner A, Lovric J, Pepic I, Filipovic-Grcic J. Lecithin/chitosan nanoparticles for transdermal delivery of melatonin. J Microencapsul 2011;28:807-15
   PubMed Web of Science ®Google Scholar
• Gelfuso GM, Gratieri T, Simao PS, Chitosan microparticles for sustaining the topical delivery of minoxidil sulphate. J Microencapsul 2011;28:650-8
   PubMed Web of Science ®Google Scholar
• Anumansirikul N, Wittayasuporn M, Klinubol P, UV-screening chitosan nanocontainers: increasing the photostability of encapsulated materials and controlled release. Nanotechnology 2008;19:205101
   PubMed Web of Science ®Google Scholar
• Gomaa YA, El-Khordagui LK, Boraei NA, Darwish IA. Chitosan microparticles incorporating a hydrophilic sunscreen agent. Carbohydr Polym 2010;81:234-42
   Web of Science ®Google Scholar
• Lehman PA, Slattery JT, Franz TJ. Percutaneous absorption of retinoids: influence of vehicle, light exposure, and dose. J Invest Dermatol 1988;91:56-61
   PubMed Web of Science ®Google Scholar
• Lira AA, Rossetti FC, Nanclares DM, Preparation and characterization of chitosan-treated alginate microparticles incorporating all-trans retinoic acid. J Microencapsul 2009;26:243-50
   PubMed Web of Science ®Google Scholar
• Perugini P, Genta I, Pavanetto F, Study on glycolic acid delivery by liposomes and microspheres. Int J Pharm 2000;196:51-61
   PubMed Web of Science ®Google Scholar
• Wisuitiprot W, Somsiri A, Ingkaninan K, Waranuch N. In vitro human skin permeation and cutaneous metabolism of catechins from green tea extract and green tea extract-loaded chitosan microparticles. Int J Cosmetic Sci 2011;33(6):572-9
   PubMed Web of Science ®Google Scholar
• Ozsoy Y, Gungor S, Cevher E. Nasal delivery of high molecular weight drugs. Molecules 2009;14:3754-79
   PubMed Web of Science ®Google Scholar
• Illum L.. Nanoparticulate systems for nasal delivery of drugs: a real improvement over simple systems? J Pharm Sci 2007;96:473-83
   PubMed Web of Science ®Google Scholar
• Jiang L, Gao L, Wang X, The application of mucoadhesive polymers in nasal drug delivery. Drug Dev Ind Pharm 2010;36:323-36
   PubMed Web of Science ®Google Scholar
• Wang X, Zheng C, Wu Z, Chitosan-NAC nanoparticles as a vehicle for nasal absorption enhancement of insulin. J Biomed Mater Res B Appl Biomater 2008;88B:150-61
   Web of Science ®Google Scholar
• Jintapattanakit A, Peungvicha P, Sailasuta A, Nasal absorption and local tissue reaction of insulin nanocomplexes of trimethyl chitosan derivatives in rats. J Pharm Pharmacol 2010;62:583-91
   PubMed Web of Science ®Google Scholar
• Zhang X, Zhang H, Wu Z, Nasal absorption enhancement of insulin using PEG-grafted chitosan nanoparticles. Eur J Pharm Biopharm 2008;68:526-34
   PubMed Web of Science ®Google Scholar
• Nagda CD, Chotai NP, Nagda DC, Development and characterization of mucoadhesive microspheres for nasal delivery of ketorolac. Pharmazie 2011;66(4):249-57
   PubMed Web of Science ®Google Scholar
• Nagda CD, Chotai NP, Nagda DC, Preparation and characterization of spray-dried mucoadhesive microspheres of ketorolac for nasal administration. Current Drug Deliv 2012;9:205-18
   PubMed Web of Science ®Google Scholar
• Gavini E, Rassu G, Ferraro L, Influence of chitosan glutamate on the in vivo intranasal absorption of rokitamycin from microspheres. J Pharm Sci 2011;100:1488-502
   PubMed Web of Science ®Google Scholar
• Brahmeshwar M, Sankar C, Madhusmita M. Polymer based solutions of bupranolol hydrochloride for intranasal systemic delivery. J Drug Target 2011;19:204-11
   PubMed Web of Science ®Google Scholar
• Sun Y, Cui F, Shi K, The effect of chitosan molecular weight on the characteristics of spray-dried methotrexate-loaded chitosan microspheres for nasal administration. Drug Dev Ind Pharm 2009;35(3):379-86
   PubMed Web of Science ®Google Scholar
• Verheul RJ, Slutter B, Bal SM, Covalently stabilized trimethyl chitosan-hyaluronic acid nanoparticles for nasal and intradermal vaccination. J Control Release 2011;156(1):46-52
   PubMed Web of Science ®Google Scholar
• Shahnaz G, Vetter A, Barthelmes J, Thiolated chitosan nanoparticles for the nasal administration of leuprolide: bioavailability and pharmacokinetic characterization. Int J Pharm 2012;428(1-2):164-70
   PubMed Web of Science ®Google Scholar
• Bal SM, Slutter B, Verheul R, Adjuvanted, antigen loaded N-trimethyl chitosan nanoparticles for nasal and intradermal vaccination: adjuvant- and site-dependent immunogenicity in mice. Eur J Pharm Sci 2012;45:475-81
   PubMed Web of Science ®Google Scholar
• Krauland AH, Guggi D, Bernkop-Schnurch A. Thiolated chitosan microparticles: a vehicle for nasal peptide drug delivery. Int J Pharm 2006;307:270-7
   PubMed Web of Science ®Google Scholar
• Gavini E, Rassu G, Muzzarelli R, Spray-dried microspheres based on methylpyrrolidinone chitosan as new carrier for nasal administration of metoclopramide. Eur J Pharm Biopharm 2008;68:245-52
   PubMed Web of Science ®Google Scholar
• Gavini E, Rassu G, Sanna V, Mucoadhesive microspheres for nasal administration of an antiemetic drug, metoclopramide: in-vitro/ex-vivo studies. J Pharm Pharmacol 2005;57:287-94
   PubMed Web of Science ®Google Scholar
• Gungor S, Okyar A, Erturk-Toker S, Ondansetron-loaded chitosan microspheres for nasal antiemetic drug delivery: an alternative approach to oral and parenteral routes. Drug Dev Ind Pharm 2010;36:806-13
   PubMed Web of Science ®Google Scholar
• Jain SK, Chourasia MK, Jain AK, Development and characterization of mucoadhesive microspheres bearing salbutamol for nasal delivery. Drug Deliv 2004;11:113-22
   PubMed Web of Science ®Google Scholar
• Gavini E, Hegge AB, Rassu G, Nasal administration of carbamazepine using chitosan microspheres: in vitro/in vivo studies. Int J Pharm 2006;307:9-15
   PubMed Web of Science ®Google Scholar
• Patil S, Babbar A, Mathur R, Mucoadhesive chitosan microspheres of carvedilol for nasal administration. J Drug Target 2010;18:321-31
   PubMed Web of Science ®Google Scholar
• Lim ST, Forbes B, Berry DJ, In vivo evaluation of novel hyaluronan/chitosan microparticulate delivery systems for the nasal delivery of gentamicin in rabbits. Int J Pharm 2002;231:73-82
   PubMed Web of Science ®Google Scholar
• Illum L, Jabbal-Gill I, Hinchcliffe M, Chitosan as a novel nasal delivery system for vaccines. Adv Drug Deliv Rev 2001;51:81-96
   PubMed Web of Science ®Google Scholar
• Howard KA, Rahbek UL, Liu X, RNA interference in vitro and in vivo using a novel chitosan/siRNA nanoparticle system. Mol Ther 2006;14:476-84
   PubMed Web of Science ®Google Scholar
• Mangal S, Pawar D, Garg NK, Pharmaceutical and immunological evaluation of mucoadhesive nanoparticles based delivery system(s) administered intranasally. Vaccine 2011;29(31):4953-62
   PubMed Web of Science ®Google Scholar
• Kannel WB, Castelli WP, Gordon T. Cholesterol in the prediction of atherosclerotic disease. new perspectives on the Framingham study. Ann Intern Med 1979;90:85-91
   PubMed Web of Science ®Google Scholar
• Yuan X, Yang X, Cai D, Intranasal immunization with chitosan/pCETP nanoparticles inhibits atherosclerosis in a rabbit model of atherosclerosis. Vaccine 2008;26(29-30):3727-34
   PubMed Web of Science ®Google Scholar
• Ali J, Ali M, Baboota S, Reflection on existence of neural and non-neural pathway for nose- to- brain using a novel formulation of an anticholinesterase piperidine derivative. Curr Nanosci 2010;6(3):320-3
   Web of Science ®Google Scholar
• Wang X, Chi N, Tang X. Preparation of estradiol chitosan nanoparticles for improving nasal absorption and brain targeting. Eur J Pharm Biopharm 2008;70:735-40
   PubMed Web of Science ®Google Scholar
• Dalpiaz A, Gavini E, Colombo G, Brain uptake of an anti-ischemic agent by nasal administration of microparticles. J Pharm Sci 2008;97:4889-903
   PubMed Web of Science ®Google Scholar
• Sheetal S, Babbar AK, Sharma RK, Pharmacoscintigraphic evaluation of polysorbate 80 coated chitosan nanoparticles for brain targeting. Am J Drug Deliv 2005;3:205-12
   Google Scholar
• Sharma BV, Ali M, Baboota S, Ali J. Preparation and characterization of chitosan nanoparticles for nose to brain delivery of a cholinesterase inhibitor. Indian J Pharm Sci 2007;69:712-13
   Google Scholar
• Charlton ST, Davis SS, Illum L. Evaluation of bioadhesive polymers as delivery systems for nose to brain delivery: in vitro characterisation studies. J Control Release 2007;118:225-34
   PubMed Web of Science ®Google Scholar
• Hartman NR, Yarchoan R, Pluda JM, Pharmacokinetics of 2',3'-dideoxyadenosine and 2',3'-dideoxyinosine in patients with severe human immunodeficiency virus infection. Clin Pharmacol Ther 1990;47:647-54
   PubMed Web of Science ®Google Scholar
• Al-Ghananeem AM, Saeed H, Florence R, Intranasal drug delivery of didanosine-loaded chitosan nanoparticles for brain targeting; an attractive route against infections caused by AIDS viruses. J Drug Target 2010;18(5):381-8
   PubMed Web of Science ®Google Scholar
• Woodley J.. Bioadhesion: new Possibilities for Drug Administration? Clin Pharmacokinet 2001;40:77-84
   PubMed Web of Science ®Google Scholar
• Chaleawlert-umpon S, Nuchuchua O, Saesoo S, Effect of citrate spacer on mucoadhesive properties of a novel water-soluble cationic beta-cyclodextrin-conjugated chitosan. Carbohyd Polym 2011;84:186-94
   Web of Science ®Google Scholar
• Mazzarino L, Travelet C, Ortega-Murillo S, Elaboration of chitosan-coated nanoparticles loaded with curcumin for mucoadhesive applications. J Colloid Interface Sci 2012;370:58-66
   PubMed Web of Science ®Google Scholar
• Hejazi R, Amiji M. Chitosan-based gastrointestinal delivery systems. J Control Release 2003;89:151-65
   PubMed Web of Science ®Google Scholar
• Caramella C, Ferrari F, Bonferoni MC, Chitosan and its derivatives as drug penetration enhancers. J Drug Deliv Sci Techn 2010;20:5-13
   Web of Science ®Google Scholar
• Yedurkar P, Dhiman MK, Petkar K, Sawant K. Mucoadhesive bilayer buccal tablet of carvedilol-loaded chitosan microspheres: in vitro, pharmacokinetic and pharmacodynamic investigations. J Microencapsul 2012;29(2):126-37
   PubMed Web of Science ®Google Scholar
• Ghosn B, van de Ven AL, Tam J, Efficient mucosal delivery of optical contrast agents using imidazole-modified chitosan. J Biomed Opt 2010;15:015003
   Web of Science ®Google Scholar
• Sandri G, Poggi P, Bonferoni MC, Histological evaluation of buccal penetration enhancement properties of chitosan and trimethyl chitosan. J Pharm Pharmacol 2006;58:1327-36
   PubMed Web of Science ®Google Scholar
• Giunchedi P, Juliano C, Gavini E, Formulation and in vivo evaluation of chlorhexidine buccal tablets prepared using drug-loaded chitosan microspheres. Eur J Pharm Biopharm 2002;53:233-9
   PubMed Web of Science ®Google Scholar
• Govender S, Pillay V, Chetty DJ, Optimisation and characterisation of bioadhesive controlled release tetracycline microspheres. Int J Pharm 2005;306:24-40
   PubMed Web of Science ®Google Scholar
• Govender S, Lutchman D, Pillay V, Enhancing drug incorporation into tetracycline-loaded chitosan microspheres for periodontal therapy. J Microencapsul 2006;23:750-61
   PubMed Web of Science ®Google Scholar
• Shen EC, Wang C, Fu E, Tetracycline release from tripolyphosphate-chitosan cross-linked sponge: a preliminary in vitro study. J Periodontal Res 2008;43:642-8
   PubMed Web of Science ®Google Scholar
• Inanc B, Elcin AE, Koc A, Encapsulation and osteoinduction of human periodontal ligament fibroblasts in chitosan-hydroxyapatite microspheres. J Biomed Mater Res A 2007;82(4):917-26
   PubMed Web of Science ®Google Scholar
• Peng L, Cheng X, Zhuo R, Novel gene-activated matrix with embedded chitosan/plasmid DNA nanoparticles encoding PDGF for periodontal tissue engineering. J Biomed Mater Res A 2009;90:564-76
   PubMed Web of Science ®Google Scholar